Liang Huang (L Huang)

Scopus Author ID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 25

Top Topics

Acute Myeloid Leukemia

Coronavirus Disease

Top Venues

Signal transduction and targeted therapy

British journal of haematology

Blood cancer journal

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology (2024)
Chuan Qin, Min Zhang, Da-Peng Mou, Luo-Qi Zhou, Ming-Hao Dong, Liang Huang, Wen Wang, Song-Bai Cai, Yun-Fan You, Ke Shang, Jun Xiao, Di Wang, Chun-Rui Li, Yi Hao, Michael Heming, Long Jun Wu, Gerd Meyer Zu Hörste, Chen Dong, Bi-Tao Bu, Dai-Shi Tian, Wei Wang
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity. Science immunology 9 (95) (2024)
Chuan Qin, Min Zhang, Da-Peng Mou, Luo-Qi Zhou, Ming-Hao Dong, Liang Huang, Wen Wang, Song-Bai Cai, Yun-Fan You, Ke Shang, Jun Xiao, Di Wang, Chun-Rui Li, Yi Hao, Michael Heming, Long Jun Wu, Gerd Meyer Zu Hörste, Chen Dong, Bi-Tao Bu, Dai-Shi Tian, Wei Wang
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity. Science immunology 9 (95) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Lu Zhang, Qin-Hua Liu, Hui Zhou, Hui-Lai Zhang, Yu-Jun Dong, Xiao-Bo Wang, Lu-Qun Wang, Li-Ping Su, Xiao-Jing Yan, Yan Li, Ming-Zhi Zhang, Kai-Yang Ding, Hui-Han Wang, Hong-Ling Peng, Li-Ye Zhong, Lin Yang, Lin-Tao Bi, Da Gao, Guang-Xun Gao, Liang Huang, Chun-Yan Sun, Jia Song, Wenbin Qian, Wen-Rong Huang, Zhen-Ling Li, Yao Liu, Jian Li
Asymptomatic multicentric Castleman disease: A potential early stage of idiopathic MCD. Blood advances (2024)
Chuan Qin, Min Zhang, Da-Peng Mou, Luo-Qi Zhou, Ming-Hao Dong, Liang Huang, Wen Wang, Song-Bai Cai, Yun-Fan You, Ke Shang, Jun Xiao, Di Wang, Chun-Rui Li, Yi Hao, Michael Heming, Long Jun Wu, Gerd Meyer Zu Hörste, Chen Dong, Bi-Tao Bu, Dai-Shi Tian, Wei Wang
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity. Science immunology 9 (95) (2024)
Ting Deng, Shiyuan Zhang, Min Xiao, Jia Gu, Liang Huang, Hongping Ba
A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 mut /CD79B mut diffuse large B-cell lymphoma. Cancer medicine 13 (4) (2024)
Chuan Qin, Dai-Shi Tian, Luo-Qi Zhou, Ke Shang, Liang Huang, Ming-Hao Dong, Yun-Fan You, Jun Xiao, Ying Xiong, Wen Wang, Hao Pang, Jing-Jing Guo, Song-Bai Cai, Di Wang, Chun-Rui Li, Min Zhang, Bi-Tao Bu, Wei Wang
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results. Signal transduction and targeted therapy 8 (1) (2023)
Chuan Qin, Dai-Shi Tian, Luo-Qi Zhou, Ke Shang, Liang Huang, Ming-Hao Dong, Yun-Fan You, Jun Xiao, Ying Xiong, Wen Wang, Hao Pang, Jing-Jing Guo, Song-Bai Cai, Di Wang, Chun-Rui Li, Min Zhang, Bi-Tao Bu, Wei Wang
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results. Signal transduction and targeted therapy 8 (1) (2023)
Chuan Qin, Dai-Shi Tian, Luo-Qi Zhou, Ke Shang, Liang Huang, Ming-Hao Dong, Yun-Fan You, Jun Xiao, Ying Xiong, Wen Wang, Hao Pang, Jing-Jing Guo, Song-Bai Cai, Di Wang, Chun-Rui Li, Min Zhang, Bi-Tao Bu, Wei Wang
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results. Signal transduction and targeted therapy 8 (1) (2023)
Chuan Qin, Dai-Shi Tian, Luo-Qi Zhou, Ke Shang, Liang Huang, Ming-Hao Dong, Yun-Fan You, Jun Xiao, Ying Xiong, Wen Wang, Hao Pang, Jing-Jing Guo, Song-Bai Cai, Di Wang, Chun-Rui Li, Min Zhang, Bi-Tao Bu, Wei Wang
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results. Signal transduction and targeted therapy 8 (1) (2023)
Jia Wei, Min Xiao, Zekai Mao, Na Wang, Yang Cao, Yi Xiao, Fankai Meng, Weimin Sun, Ying Wang, Xingcheng Yang, Liting Chen, Yicheng Zhang, Haichuan Zhu, Shangkun Zhang, Tongcun Zhang, Jian-Feng Zhou, Liang Huang
Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT. Signal transduction and targeted therapy 7 (1) (2022)
Li-Li Gao, Li Yang, Liang Huang, Yi Xiao, Jinniu Deng, Miao Zheng, Hui Luo, Lijun Jiang, Min Xiao, Chun-Rui Li, Jianfeng Zhou
Clinical and genetic features of Epstein-Barr virus-triggered late-onset primary hemophagocytic lymphohistiocytosis: Ten pedigrees study. Clinical and translational medicine 11 (6) (2022)
Dan Li, Yimei Que, Shengnan Ding, Guang Hu, Wen Wang, Xia Mao, Ying Wang, Chun-Rui Li, Liang Huang, Jianfeng Zhou, Wei Zhang, Min Xiao
Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report. Journal for immunotherapy of cancer 10 (9) (2022)
Di Wang, Xia Mao, Yimei Que, Menglei Xu, Yuhang Cheng, Liang Huang, Jue Wang, Yi Xiao, Wen Wang, Guang Hu, Shangkun Zhang, Tongcun Zhang, Chun-Rui Li, Jian-Feng Zhou
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy. Blood cancer journal 11 (10) (2021)
Jiachen Wang, Zhen Shang, Jue Wang, Jinhuan Xu, Weigang Li, Yuqi Guan, Li Yang, Wei Zhang, Kefeng Shen, Meilan Zhang, Jin Wang, Liting Chen, Qinlu Li, Cheng He, Na Wang, Liang Huang, Yi Xiao, Min Xiao, Jianfeng Zhou
MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy. Journal for immunotherapy of cancer 9 (6) (2021)
Xuelian Hu, Haodong Cai, Lu Zheng, Yi Luo, Jing Zhou, Yan Hui, Zhenyu Dai, Haolong Lin, Dengju Li, Yi Xiao, Liang Huang, Jianfeng Zhou
Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia. Cancer medicine 9 (14) (2020)
Yifan Meng, Ping Wu, Wanrong Lu, Kui Liu, Ke Ma, Liang Huang, Jiaojiao Cai, Hong Zhang, Yu Qin, Haiying Sun, Wencheng Ding, Lingli Gui, Peng Wu
Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS pathogens 16 (4) (2020)
D Wang, C Zeng, B Xu, J-H Xu, J Wang, L-J Jiang, Q-X Wang, Chun-Rui Li, N Wang, Liang Huang, Y-C Zhang, Y Xiao, J-F Zhou
Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients. Blood cancer journal 10 (1) (2020)
Dan Li, Tongjuan Li, Zhen Shang, Lei Zhao, Qian Xu, Jiaqi Tan, Yun Qin, Yuanyuan Zhang, Yang Cao, Na Wang, Liang Huang, Xiaojian Zhu, Kuangguo Zhou, Liting Chen, Chunrui Li, Ting Xie, Yi Yang, Jue Wang, Jianfeng Zhou
Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD+ acute myeloid leukemia. Signal transduction and targeted therapy 5 (1) (2020)
Hexiu Su, Juncheng Hu, Liang Huang, Yang Yang, Morgan Thenoz, Anna Kuchmiy, Yufeng Hu, Peng Li, Hui Feng, Yu Zhou, Tom Taghon, Pieter Van Vlierberghe, Guoliang Qing, Zhichao Chen, Hudan Liu
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival. Nature communications 9 (1) (2018)
Y-T Tang, D Wang, H Luo, M Xiao, H-S Zhou, D Liu, S-P Ling, N Wang, X-L Hu, Y Luo, X Mao, Q-L Ao, J Huang, W Zhang, L-S Sheng, L-J Zhu, Z Shang, L-L Gao, P-L Zhang, M Zhou, K-G Zhou, L-G Qiu, Q-F Liu, H-Y Zhang, J-Y Li, J Jin, L Fu, W-L Zhao, J-P Chen, X Du, G Huang, Q-F Wang, J-F Zhou, Liang Huang
Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes. Blood cancer journal 7 (12) (2017)
Y Hu, H Su, C Liu, Z Wang, Liang Huang, Q Wang, S Liu, S Chen, J Zhou, Peng Li, Z Chen, H Liu, G Qing
DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia. Oncogene 36 (8) (2016)